Cargando…

Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care

BACKGROUND: Prescribing high doses of methotrexate increases the potentially fatal risk of toxicity. To minimise risk, it is recommended that only 2.5 mg tablets are used. AIM: To describe trends in GP prescribing of methotrexate over time; the harm associated with methotrexate errors at a national...

Descripción completa

Detalles Bibliográficos
Autores principales: MacKenna, Brian, Curtis, Helen J, Walker, Alex J, Croker, Richard, Bacon, Seb, Goldacre, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311108/
https://www.ncbi.nlm.nih.gov/pubmed/32571771
http://dx.doi.org/10.3399/bjgp20X710993
_version_ 1783549496104321024
author MacKenna, Brian
Curtis, Helen J
Walker, Alex J
Croker, Richard
Bacon, Seb
Goldacre, Ben
author_facet MacKenna, Brian
Curtis, Helen J
Walker, Alex J
Croker, Richard
Bacon, Seb
Goldacre, Ben
author_sort MacKenna, Brian
collection PubMed
description BACKGROUND: Prescribing high doses of methotrexate increases the potentially fatal risk of toxicity. To minimise risk, it is recommended that only 2.5 mg tablets are used. AIM: To describe trends in GP prescribing of methotrexate over time; the harm associated with methotrexate errors at a national level; ascertain variation between practices and clinical commissioning groups (CCGs) in their implementation of the safety guidance; and map current variations at CCG and practice level. DESIGN AND SETTING: A retrospective cohort study of English GP prescribing data (August 2010–April 2018), and data acquired via freedom of information (FOI) requests. METHOD: The main outcome measures were: variation in ratio of non-adherent/adherent prescribing, geographically and over time, between practices and CCGs; and description of responses to FOI requests. RESULTS: Of 7349 practices in England, 1689 prescribed both 2.5 mg and 10 mg tablets to individual patients in 2017, breaching national guidance. In April 2018, 697 practices (≥90th percentile) prescribed >14.3% of all methotrexate as 10 mg tablets, likewise breaching national guidance. The 66 practices at ≥99th percentile gave >52.4% of all prescribed methotrexate in the form of 10 mg tablets. The prescribing of 10 mg tablets fell during the study period, with 10 mg tablets as a proportion of all prescribed methotrexate tablets falling from 9.1% to 3.4%. Twenty-one deaths caused by methotrexate poisoning were reported from 1993–2017 in England and Wales. CONCLUSION: The prevalence of unsafe methotrexate prescribing has reduced but remains common, with substantial variation between practices and CCGs. The authors recommend investment in better strategies around implementation. As 21 deaths that occurred from 1993–2017 in England and Wales were attributed to methotrexate poisoning, the coroners’ reports for these deaths should be reviewed to identify recurring themes.
format Online
Article
Text
id pubmed-7311108
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-73111082020-06-24 Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care MacKenna, Brian Curtis, Helen J Walker, Alex J Croker, Richard Bacon, Seb Goldacre, Ben Br J Gen Pract Research BACKGROUND: Prescribing high doses of methotrexate increases the potentially fatal risk of toxicity. To minimise risk, it is recommended that only 2.5 mg tablets are used. AIM: To describe trends in GP prescribing of methotrexate over time; the harm associated with methotrexate errors at a national level; ascertain variation between practices and clinical commissioning groups (CCGs) in their implementation of the safety guidance; and map current variations at CCG and practice level. DESIGN AND SETTING: A retrospective cohort study of English GP prescribing data (August 2010–April 2018), and data acquired via freedom of information (FOI) requests. METHOD: The main outcome measures were: variation in ratio of non-adherent/adherent prescribing, geographically and over time, between practices and CCGs; and description of responses to FOI requests. RESULTS: Of 7349 practices in England, 1689 prescribed both 2.5 mg and 10 mg tablets to individual patients in 2017, breaching national guidance. In April 2018, 697 practices (≥90th percentile) prescribed >14.3% of all methotrexate as 10 mg tablets, likewise breaching national guidance. The 66 practices at ≥99th percentile gave >52.4% of all prescribed methotrexate in the form of 10 mg tablets. The prescribing of 10 mg tablets fell during the study period, with 10 mg tablets as a proportion of all prescribed methotrexate tablets falling from 9.1% to 3.4%. Twenty-one deaths caused by methotrexate poisoning were reported from 1993–2017 in England and Wales. CONCLUSION: The prevalence of unsafe methotrexate prescribing has reduced but remains common, with substantial variation between practices and CCGs. The authors recommend investment in better strategies around implementation. As 21 deaths that occurred from 1993–2017 in England and Wales were attributed to methotrexate poisoning, the coroners’ reports for these deaths should be reviewed to identify recurring themes. Royal College of General Practitioners 2020-06-23 /pmc/articles/PMC7311108/ /pubmed/32571771 http://dx.doi.org/10.3399/bjgp20X710993 Text en ©The Authors http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/).
spellingShingle Research
MacKenna, Brian
Curtis, Helen J
Walker, Alex J
Croker, Richard
Bacon, Seb
Goldacre, Ben
Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
title Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
title_full Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
title_fullStr Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
title_full_unstemmed Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
title_short Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care
title_sort trends and variation in unsafe prescribing of methotrexate: a cohort study in english nhs primary care
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311108/
https://www.ncbi.nlm.nih.gov/pubmed/32571771
http://dx.doi.org/10.3399/bjgp20X710993
work_keys_str_mv AT mackennabrian trendsandvariationinunsafeprescribingofmethotrexateacohortstudyinenglishnhsprimarycare
AT curtishelenj trendsandvariationinunsafeprescribingofmethotrexateacohortstudyinenglishnhsprimarycare
AT walkeralexj trendsandvariationinunsafeprescribingofmethotrexateacohortstudyinenglishnhsprimarycare
AT crokerrichard trendsandvariationinunsafeprescribingofmethotrexateacohortstudyinenglishnhsprimarycare
AT baconseb trendsandvariationinunsafeprescribingofmethotrexateacohortstudyinenglishnhsprimarycare
AT goldacreben trendsandvariationinunsafeprescribingofmethotrexateacohortstudyinenglishnhsprimarycare